about
Renal amyloidosis secondary to hidradenitis suppurativa.Anakinra use during pregnancy: Report of a case with Familial Mediterranean Fever and infertility.Anti-angiotensin II type 1 receptor autoantibodies (AT1R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations.Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis.Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.Familial discoid lupus erythematosus evolving to systemic lupus erythematosus with lung involvement after more than a decade in older adults.Upper Abdominal Activity in Bone Scan.A Case of Amyloidosis Caused by Sporadic Muckle-Wells Syndrome: Response to Treatment With Anakinra.Near-complete recanalization of jugular vein and multiple dural sinus thromboses with warfarin in a case of antiphospholipid syndromeBull’s Head Sign in a Patient with SAPHO SyndromeAutoimmune disease, tumor necrosis factor inhibitors and acute leukemia: possible associations in two patients?An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosisThe Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic SclerosisA Rare Case of Granulomatosis With Polyangiitis With Cardiac and Splenic InvolvementsHidradenitis suppurativa and Mediterranean fever gene mutationsMEditerranean FeVer ( MEFV ) gene mutations in glomerulonephritides: a clinicopathological studySerum pentraxin-3 levels in acute cholecystitis: Helpful in emergency decision-making?Quantitative Assessment of Salivary Gland Parenchymal Vascularization Using Power Doppler Ultrasound and Superb Microvascular Imaging: A Potential Tool in the Diagnosis of Sjögren's SyndromeLess IgA deposits with more severe disease: the immunoclinical paradox in Henoch-Schönlein Purpura with MEFV mutationsAssociation of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosisComplexity of familial Mediterranean fever geneticsSerum pentraxin-3 follows a logarithmic distribution particularly at low expected levelsDifferent pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?
P50
Q35626499-C814A578-4401-4012-8CBC-78D017F08856Q37679308-A52EA996-9C28-444A-9D4F-CACF9C0356E7Q39076219-3BD0889A-7B14-4E70-BA41-B0C400BDD927Q39160620-BCD723D9-6FC0-4EBE-A11E-ADDA32DE7589Q40100395-9DFF4744-CDEB-40D8-A00C-47D0BA1D451DQ48159962-8B16478B-1B8E-4563-B9E3-80EA4A4F785EQ48270777-F3EEE919-5A80-4F2F-9770-234D41D3DDD6Q48332309-EB3C2E00-8C92-46AD-AEEF-B1E8BE0D3790Q49843527-53FE0406-2C01-45A8-A315-BDDFB8D4490CQ60935758-E2C474F7-2C14-46D8-8330-7D3044277C98Q64085713-7B03C997-ADF5-4C9E-A5A5-8B25CEFDA92AQ86642305-40D3A523-78BC-42B8-BB55-376CE51545D6Q87876638-943BDF1C-C160-4BD2-A160-DDD00AA51E04Q89099219-83875069-6189-4664-B962-6A8560F035AEQ90121919-81631FD1-F3FB-4380-9CF6-A03F08A7B93FQ90138388-4184B1A4-261C-4598-AB40-EAD7E064E70EQ90430583-9575A726-B062-425D-BBD7-AA5897CBAF2AQ91413414-FA3F2C19-4C0B-4F68-B3E7-181A24E59BAAQ91753013-3574594C-08EF-4993-ACAF-FAA4775603A5Q91978660-2FD4D47A-C2EA-489C-8A89-3E38FF7D910FQ91978669-16A67B4B-4B13-4683-BFEE-1512B1A5588CQ92072234-3C16DCEC-32C4-4E9A-997C-B01F4FDFAE5AQ92656517-F7B8556C-39AA-4401-9CAD-9A38D52B0736Q92971197-72B60613-552D-494C-B715-06EE20A5F3C1
P50
description
Turkish rheumatologist
@en
name
Ufuk İlgen
@ast
Ufuk İlgen
@en
Ufuk İlgen
@es
Ufuk İlgen
@nl
type
label
Ufuk İlgen
@ast
Ufuk İlgen
@en
Ufuk İlgen
@es
Ufuk İlgen
@nl
prefLabel
Ufuk İlgen
@ast
Ufuk İlgen
@en
Ufuk İlgen
@es
Ufuk İlgen
@nl
P106
P1153
55964991700
P21
P27
P31
P4012
P496
0000-0001-6443-6426